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Bone morphogenetic proteins (BMPs) are multifunctional growth factors implicated 
in multiple biological events. Studies on mice, chickens and other experimental ani-
mals have shown that BMP signalling plays critical role in embryonic development, 
in particular in the neural patterning. In our study we comparatively evaluated 
BMP-2 and BMP-4 protein expression in the developing spinal cord of human and 
rat embryos. The human and rat embryos of Carnegie stages 14, 18 and 20 were 
embedded in paraffin and cut serially in transversal direction. BMP-2 and BMP-4 were 
detected by immunohistochemical staining. Spatial and temporal expression pattern 
of BMP-s during early stages of spinal cord development was similar in human and 
rat embryos. Higher expression of BMP-s was seen in the dorsal and lower expression 
in the ventral part of the developing spinal cord both in human and rat embryos. 
However, temporal difference in the expression of BMPs in the non-neural ectoderm 
between human and rat embryos was noted. Staining of BMP-s in the non-neural 
ectoderm adjacent to the developing spinal cord in the human embryos seemed to 
have a tendency to decrease from earlier to later developmental stages, while in rat 
embryos there was an opposite tendency. (Folia Morphol 2015; 74, 3: 359–364)
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INTRODUCTION
Bone morphogenetic proteins (BMPs) are signal-
ling molecules that act at distance to control cell fate 
in the developing embryos. Although BMPs were 
originally identified by an ability to induce the for-
mation of cartilage and bone, it is now generally 
accepted that BMPs are among the key regulators 
in the embryonic development guiding many criti-
cal steps in the formation of various cells, tissues 
and organs [4, 10]. BMPs in conjunction with other 
important regulatory factors like Sonic Hedgehog 
(SHH), WNT and FGF family members are believed 
to coordinate neural tube development and cellular 
proliferation [10, 13, 15]. Experimental data from 
studies mainly on mice and chickens have provided 
evidence that BMPs are implicated in the patterning 
of the developing central nervous system (CNS) [3, 5], 
in particular BMPs have been shown to regulate 
dorso-ventral patterning of the vertebrate spinal cord 
[14, 16]. Although BMP activity must be inhibited to 
allow initial neural fate determination, it is clear that 
BMP signalling positively regulates CNS development 
at later stages [13]. Once the neural tissue is estab-
lished, BMP-2 and BMP-4 signalling has a positive 
influence on the regulation of dorsal neural cell type 
formation [10]. Several studies have demonstrated 
that formation and regionalisation of spinal cord is 
highly dependent on activity of the roof plate sig-
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nalling activity. As the caudal neural tube closes the 
roof plate progenitors differentiate into mature roof 
plate cells, which occupy the dorsal-midline region 
and act as an organising centre controlling numerous 
aspects of dorsal spinal cord development [1, 2]. In 
studies both on mice and chickens expression of BMPs 
in the roof plate during neural tube development at 
the time of dorsal neuronal cells formation has been 
clearly shown [7, 8]. 
In our previous study on human embryos we fou-
nd strong BMP-2 and BMP-4 protein expression in the 
dorsal part of the developing spinal cord, including 
also the roof plate region [11]. In order to see if this 
temporal and spatial BMP-2 and BMP-4 protein ex-
pression pattern found in the forming nervous system 
of human embryos is equally similar to the situation 
in embryos of other mammals we aimed in this study 
to compare the BMP-2 and BMP-4 expression in the 
developing spinal cord of human and rat embryos 
throughout early stages of development.
MATERIALS AND METHODS
Obtaining embryos and section preparation
Twenty two human embryos of Carnegie stages 
(CS) 14, 18 and 20 were obtained by medical abor-
tions. The study was approved by the Ethics Review 
Committee on Human Research of the University of 
Tartu. 22 Sprague Dawley strain rat embryos of CS 
14, 18 and 20 were used in this study (rat embryos 
were obtained from the Umea University, Sweden). 
The human and rat embryos were fixed in 4% para-
formaldehyde and embedded in paraffin according 
to standard methods. Tissue blocks were serially cut 
in transversal direction and mounted on glass slides. 
Embryos were classified by CS [12]. The deve-
lopmental stages and the number of embryos used in 
this study are presented in Table 1. This table also 
presents an approximate comparison of human and 
rat embryos based upon Carnegie staging. 
Immunohistochemistry
Three-µm thick paraffin sections mounted on poly-
-L-lysine coated slides were deparaffinised and rehy-
drated. Peroxidase activity was blocked by 0.6% H2O2 
in methanol (Merck, Darmstadt, Germany). Then the 
sections were washed in tap water and in phosphate 
buffered saline (PBS) (pH = 7.4) for 10 min, treated 
with normal 1.5% goat serum (Gibco, Invitrogen 
Corporation, USA) for 20 min at room temperature 
and incubated overnight at 4oC with the primary an-
tibody: rabbit polyclonal antibody to BMP-2 (Abcam, 
Cambridge, UK, diluted 1:250) or rabbit polyclonal 
antibody to BMP-4 (Abcam, Cambridge, UK, diluted 
1:100). The next day, sections were washed in PBS and 
incubated with the secondary antibody (VECTASTAIN 
ABC Universal Kit, Burlingame, USA) for 30 min at 
room temperature. Peroxidatic activity was detected 
with 3.3’-diaminobenzidine (DAB; Vector, Burlingame, 
USA) and sections were counterstained with haema-
toxylin. BMP-2 and BMP-4 labelling was expressed 
by a subjective scale ranging from 0 to 3 (0 — no 
staining, 1 — weak staining, 2 — moderate staining, 
3 — strong staining). Immunohistochemistry negative 
controls were performed by omitting the primary 
antibody. BMP-2 and BMP-4 immunohistochemical 
staining was evaluated in the developing spinal cord 
separately in its dorsal and ventral parts. Also, staining 
was evaluated in the adjacent non-neural ectoderm. 
Two independent observers evaluated the intensity 
staining; the mean of estimations was calculated and 
used for statistical analysis. The data were analysed 
by Kruskal-Wallis test (nonparametric ANOVA). The 
level of significance was set at p < 0.05.
RESULTS
Expression of BMP-2 and BMP-4, as determined 
by immunohistochemistry, was observed in the spi-
nal cord at all developmental stages analysed in this 
study (CS 14, CS 18 and CS 20). BMP-2 signal in the 
developing spinal cord was found to be stronger 
compared to BMP-4 both in human and rat embryos 
(Table 2, Figs. 1–4). BMP-2 and BMP-4 exhibited si-
milar immunolocalisation and expression patterns — 
there was slight, statistically insignificant tendency for 
expression to decline at later stages of development. 
However, the developing spinal cord of rat embryos 
Table 1. Number of studied embryos, developmental Carnegie 
stages (CS) and age in postovulatory days of investigated hu-
man and rat embryos
CS 14 18 20
Human 
embryos
Number of embryos 7 5 10
Developmental days 31–35 44–48 51–53
Rat  
embryos
Number of embryos 7 5 10
Developmental days 13 15 18 
The table shows an approximate comparison of days of development in human and rat 
embryos based upon Carnegie staging. 
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Table 2. Immunohistochemical estimation of bone morphogenetic proteins (BMP)-2 and BMP-4 in the spinal cord and non-neural ecto-
derm of the human and rat embryos at different developmental stages
BMP-2 BMP-4
CS 14 CS 18 CS 20 CS 14 CS 18 CS 20
Human  
embryos
DP 2.4 ± 0.06a,g 2.3 ± 0.04b,h 2.2 ± 0.09c,i 2.2 ± 0.03d,j 1.9 ± 0.10e,k 1.9 ± 0.10f,l
VP 1.8 ± 006a 1.6 ± 0.05b 1.8 ± 0.10c 1.0 ± 0.05d 1.0 ± 0.10e 1.0 ± 0.03f
NE 2.6 ± 0.08m,r 2.3 ± 0.14n 1.9 ± 0.03r 1.7 ± 0.03o 1.8 ± 0.08p 1.4 ± 0.07
Rat  
embryos
DP 1.6 ± 0.06g 1.6 ± 0.10h 1.4 ± 0.05i 1.3 ± 0.08j 1.2 ± 0.06k 1.2 ± 0.08l
VP 1.0 ± 0.04 1.1 ± 0.05 0.9 ± 0.05 0.8 ± 0.06 0.8 ± 0.07 0.7 ± 0.08
NE 1.8 ± 0.04m 1.4 ± 0.12n,s 2.1 ± 0.05s 0.9 ± 0.12o,t 1.0 ± 0.06p 1.5 ± 0.11t
CS — Carnegie stages; DP — dorsal part of the developing spinal cord; VP — ventral part of the developing spinal cord; NE — non-neural ectoderm. Immunostaining intensity was graded 
from weak (1) to strong (3), the data are presented as mean ± SEM. Significant differences (p < 0.05) in staining intensity between groups are indicated with the same letter
Figure 1. Transversal section of the developing spinal cord of human 
embryo at Carnegie stage 18. Arrows indicate stronger expression  
of the bone morphogenetic protein-2 in (BMP-2) neuronal cells. 
Figure 2. Transversal section of the developing spinal cord of hu-
man embryo at Carnegie stage 18. Arrows indicate weaker expres-
sion of the bone morphogenetic protein-4 (BMP-4) in neuronal cells.
Figure 3. Transversal section of the developing spinal cord of rat 
embryo at Carnegie stage 18. Arrows indicate moderate expres-
sion of bone morphogenetic protein-2 in (BMP-2) neuronal cells.
Figure 4. Transversal section of the developing spinal cord of rat 
embryo at Carnegie stage 18. Arrows indicate weaker expression 
of bone morphogenetic protein-4 (BMP-4) in neuronal cells.
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showed weaker immunostaining of BMP-s (Figs. 3, 4) 
compared to human embryos (Figs. 1, 2; Table 2). 
Especially weak staining intensity of BMP-4 was de-
tected in the rat embryos at CS 20 (Table 2, Fig. 5). 
In negative controls where the primary antibodies 
to BMP-2 or BMP-4 were omitted no staining was 
detected (Fig. 6).
In the developing spinal cord expression of BMP-2 
and BMP-4 was evaluated separately in the roof plate, 
floor plate and adjacent non-neural ectoderm (Table 2). 
Statistically significant stronger immunostaining in-
tensity of BMP-s was detected in the dorsal part of 
both human and rat embryos spinal cord as compa-
red to the ventral parts. At the end of the 5th week 
of human and 13 days of rat embryos development 
(CS 14) 3 zones could be distinguish in the wall of 
the spinal cord: the ventricular, mantel and marginal 
layer. A comparison of differences between dorsal and 
ventral part in the spinal cord showed that in human 
embryos staining intensity of BMP-2 and BMP-4 was 
more extensive in 3 layers of the dorsolateral (alar) 
plates than in ventrolateral (basal) plates (Figs. 7, 8). 
Similarly, more intensive staining of BMP-2 and BMP-4 
was noticed in dorsal parts of the rat spinal cord 
(Table 2). Also in rat embryos expression of BMP-2 was 
detected in the ventricular, mantel and basal layers in 
CS 14–23 of the spinal cord (Fig. 9), but expression of 
BMP-4 was weaker. Expression of BMP-2 and BMP-4 in 
the roof plate cells was found in both human and rat 
embryos at all studied CS. We also noticed expression 
of BMP-2 and BMP-4 in the floor plate (Fig. 8), but 
expression was found to be less intensive than in the 
roof plate (Figs. 7, 9). 
Figure 5. Transversal section of the developing spinal cord of rat 
embryos at Carnegie stage 20. Arrows indicate very weak expression 
of bone morphogenetic protein-4 (BMP-4) in neuronal cells.
Figure 6. Transversal section of the developing spinal cord of  
human embryo at Carnegie stage 18. Negative control, arrows  
indicate no staining intensity in neuronal cells.
Figure 7. Transversal section of the dorsal part of developing spinal 
cord of human embryo at Carnegie stage 14. Expression of bone 
morphogenetic protein-4 (BMP-4) in: a — ventricular layer; b — 
mantel layer; c — marginal layer; arrows indicate roof plate cells. 
Figure 8. Transversal section of the ventral part of developing spinal 
cord of human embryo at Carnegie stage 14. Expression of bone 
morphogenetic protein-4 (BMP-4) in: a — ventricular layer; b — 
mantel layer; c — marginal layer; arrows indicate floor plate cells.
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of human and rat embryos. The results, summarised 
in Table 2, show the temporal pattern of BMP-2 and 
BMP-4 expression during spinal cord morphogenesis. 
Our estimations of BMP-2 and BMP-4 immunostaining 
in the dorsal and ventral parts of the developing 
spinal cord of human and rat embryos throughout 
developmental stages CS 14–20 are in general in 
accordance with data obtained from animal studies. 
Several investigations in experimental animals, mai-
nly mice and chickens, have demonstrated that the 
normal development of the spinal cord is tightly 
regulated by BMP signalling [13]. High levels of BMP 
signalling set up the most dorsally located precursor 
cells and lower levels of signalling define ventrally 
located cells. The regionalisation of the precursor cells 
leads to the formation of distinct dorsal and ventral 
neuronal cell types [6, 10]. In our study stronger im-
munostaining of BMP-s was seen in the dorsal part 
of the developing spinal cord: higher expression of 
BMP-2 and BMP-4 was noted in the ventricular, mantel 
and marginal layers of the dorsal part in developing 
spinal cord of both human and rat embryos (Figs. 7, 9), 
while staining in the ventral part was weaker (Fig. 8). 
Similar expression gradient of BMP-s has been fou-
nd in other experimental animals [6, 10, 13]. In our 
study on human and rat embryos, BMP-2 and BMP-4 
expression was also noted in the roof plate (Fig. 7), 
which is in concordance with studies on mice, where 
it is demonstrated that BMP-s mediated signals from 
the roof plate are required for the differentiation of 
neuronal cells in the dorsal spinal cord [1, 2]. 
Comparing staining estimations of BMP-2 and 
BMP-4 in the dorsal part of the developing spinal 
cord there were no significant differences between 
the consecutive developmental stages (from CS 14 
to CS 20) both in human and rat embryos, though 
slight declining tendency was noted in later deve-
lopmental stages (Table 2). However, this tendency 
was more visible in our previous study on neural tubes 
of human embryos where more earlier developmental 
stages were investigated, in particular clear differen-
ces in BMP-4 immunostaining intensity was noticed 
with higher level at CS 10 and lower level at CS 20 
[11]. This seems to support the idea that the roles of 
BMP-s are the most significant after the neural tube 
closing when the differentiation of the neural tube 
begins [10]. 
Although resembling descriptions in experimental 
animals, human BMP-2 and BMP-4 immunostaining 
in the developing spinal cord displayed slight diffe-
Figure 9. Transversal section of the dorsal part of developing spi-
nal cord of rat embryo at Carnegie stages 20. Expression of bone 
morphogenetic proteins-2 in: a — ventricular layer; b — mantel 
layer; c — marginal layer; arrows indicate roof plate cells.
Figure 10. Transversal section of the developing spinal cord and 
non-neural ectoderm of human embryo at Carnegie stages 18; a — 
expression of bone morphogenetic proteins-2 (BNP-2) in non-neural 
ectoderm; b — expression of BMP-2 in developing spinal cord.
The expression of BMP-2 and BMP-4 in human 
and rat embryonic non-neural ectoderm was detec-
ted from anterior to posterior level of the forming 
spinal cord. In the non-neural ectoderm of human 
embryos BMP-2 and BMP-4 staining was found to be 
stronger in early stages and weaker in later stages of 
development (Fig. 10), especially significant higher-
-level expression of BMP-2 was seen at CS 14 (Table 2). 
Differently from human embryos, BMP-2 and BMP-4 
staining in the non-neural ectoderm of rat embryos 
was weaker in CS 14–18. 
DISCUSSION
In the present study we compared the expression 
of BMP-2 and BMP-4 in the developing spinal cord 
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rences in their expression pattern when compared 
to rat embryos. It refers to the higher expression of 
both proteins in the dorsal part of the developing 
spinal cord of human embryos. Also, when in human 
embryos BMP-2 and BMP-4 immunostaining in the 
non-neural ectoderm declined throughout the con-
secutive developmental stages, then in rat embryos 
there was an opposite tendency as the expression of 
BMP-s increased from CS 14 to CS 20 (Table 2). There 
is evidence from studies on chick spinal cord that 
BMP-2 and BMP-4 produced by dorsal non-neural 
ectoderm (surface ectoderm) function as dorsalizing 
signals to pattern adjacent neuroectoderm [7–9, 14]. 
The strong to moderate level of BMP-2 and BMP-4 
protein expression in the non-neural ectoderm seen in 
our study suggest that BMP-s could likely have similar 
involvement in the dorsal neural tube development 
of the human embryos, especially in the early stages 
of development (Table 2).
CONCLUSIONS
It can be concluded that protein expressions of 
BMP-2 and BMP-4 in the developing spinal cord of 
human embryos during the studied CS 14, CS 18 and 
CS 20 have similar spatial and temporal pattern to the 
corresponding stages of rat embryos. Similarly higher 
expression of BMP-s in the dorsal and lower expression 
in the ventral part of the developing spinal cord was 
seen in both human and rat embryos thus resembling 
the situation described in other vertebrates. However, 
in the non-neural ectoderm adjacent to the developing 
spinal cord staining of BMP-s in the human embryos 
seemed to have a tendency to decrease from earlier to 
later developmental stages, while in rat embryos the 
situation was in opposite as the staining of BMP-s was 
found to be stronger in the last studied developmental 
stage compared to the earlier stages.
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